Van Akkooi Alexander CJ,...,Matkovic Suzana V,...,(broj koautora 38) (2026) primary analysis of the RANDOMIZED eortc-2139/columbus-ad trial: Adjuvant encorafenib and binimetinib versus placebo in high-risk stage II BRAF-V600E/K melanoma, EUROPEAN JOURNAL OF CANCER, vol. 245, br. , str. - (Article) 

Mirjacic-Martinovic Katarina M,Vuletic Ana M,Tisma-Miletic Nevena,Nedeljkovic Milica D,Matkovic Suzana V,Jurisic Vladimir B (2025) Analyses of peripheral blood NK cells in response to anti-PD-1 therapy in metastatic melanoma patients, CLINICAL IMMUNOLOGY, vol. 280, br. , str. - (Article) 

Mirjacic-Martinovic Katarina M,Vuletic Ana M,Tisma-Miletic Nevena,Matkovic Suzana V,Gavrilovic Dusica,Ninkovic Aleksandra Z,Jurisic Vladimir B,Babovic Nada Lj (2024) Circulating IL-6 is associated with disease progression in BRAFwt metastatic melanoma patients receiving anti-PD-1 therapy, JOURNAL OF CLINICAL PATHOLOGY, vol. 77, br. 5, str. 343-351 (Article) 

Sladojevic Jovana,Dotlic Jelena R,Gazibara Tatjana M,Matkovic Suzana V,Maksimovic Natasa S (2023) Longitudinal evaluation of health-related quality of life after removal of high-risk melanoma in a setting where adjuvant therapy is not available, ARCHIVES OF DERMATOLOGICAL RESEARCH, vol. 316, br. 1, str. - (Article) 

Mirjacic-Martinovic Katarina M,Vuletic Ana M,Tisma-Miletic Nevena,Besu-Zizak Irina V,Milovanovic Jelena RA,Matkovic Suzana V,Jurisic Vladimir B (2023) Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients, TRANSLATIONAL ONCOLOGY, vol. 38, br. , str. - (Article) 

Mirjacic-Martinovic Katarina M,Vuletic Ana M,Tisma-Miletic Nevena,Nedeljkovic Milica D,Babovic Nada Lj,Matkovic Suzana V,Jurisic Vladimir B (2023) Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients, INNATE IMMUNITY, vol. 29, br. 3-4, str. 37-44 (Article) 

Nikic Predrag Z,Babovic Nada Lj,Dzamic Zoran M,Salma Svetlana,Stojanovic Vesna,Matkovic Suzana V,Pejcic Zoran,Juskic Kristina,Soldatovic Ivan A (2022) Real World Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Only Available Sunitinib and Pazopanib in First-Line Setting, FRONTIERS IN ONCOLOGY, vol. 12, br. , str. - (Article) 

Matkovic Suzana V,Dotlic Jelena R,Gazibara Tatjana M,Maric Gorica D,Nikolic Vladimir,Maksimovic Natasa S (2021) Functional assessment of cancer therapy questionnaire for melanoma in the Serbian population: A factor analytic approach, PLOS ONE, vol. 16, br. 6, str. - (Article) 

Mirjacic-Martinovic Katarina M,Babovic Nada Lj,Dzodic Radan R,Jurisic Vladimir B,Matkovic Suzana V,Konjevic Gordana M (2015) Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients, JOURNAL OF TRANSLATIONAL MEDICINE, vol. 13, br. , str. - (Article) 

Milanovic Nenad,Matkovic Suzana V,Ristic Dusan J,Jelic Svetislav B,Petrovic Milan D (2012) Significance of tumor burden, vascular endothelial growth factor, lactate dehydrogenase and beta-2 microglobulin serum levels in advanced diffuse large B cell lymphoma, JOURNAL OF BUON, vol. 17, br. 3, str. 497-501 (Article) 

Juranic Zorica D,Besu Irina V,Jelic Svetislav B,Konic-Ristic Aleksandra I,Matkovic Suzana V,Jankovic Ljiljana B,Gavrilovic Dusica,Radojcic Branka S,Minic Ivana Z (2009) Some patients with NHL possessed immunoreactivity to gliadin and to cow's milk proteins, INTERNATIONAL JOURNAL OF HEMATOLOGY, vol. 90, br. 2, str. 212-216 (Article) 

Juranic Zorica D,Radic Jelena,Konic-Ristic Aleksandra I,Jelic Svetislav B,Mihaljevic Biljana S,Stankovic Ivan M,Matkovic Suzana V,Besu Irina V,Gavrilovic Dusica (2008) Humoral immunoreactivity to gliadin and to tissue transglutaminase is present in some patients with multiple myeloma, BMC IMMUNOLOGY, vol. 9, br. , str. - (Article) 

Jelic Svetislav B,Babovic Nada Lj,Stamatovic Ljiljana,Kreacic Miroslav,Matkovic Suzana V,Popov Ivan P (2001) Vinblastin-carboplatin for metastatic cutaneous melanoma as first-line chemotherapy and in dacarbazine failures - A single-center study, MEDICAL ONCOLOGY, vol. 18, br. 3, str. 189-195 (Article) 

Jelic Svetislav B,Babovic Nada Lj,Kreacic Miroslav,Matkovic Suzana V,Milanovic Nenad,Gavrilovic Dusica,Tomasevic Zoran M (1999) Epirubicin 150 mg/m(2)-cisplatin versus epirubicin 180 mg/m(2)-cisplatin for advanced soft tissue sarcoma, INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, vol. 19, br. 4, str. 129-138 (Article) 

Jelic Svetislav B,Milanovic Nenad,Tomasevic Zorica I,Matkovic Suzana V,Gavrilovic Dusica (1999) Comparison of two non-anthracycline-containing regimens for elderly patients with diffuse large-cell non Hodgkin's lymphoma - possible pitfalls in results reporting and interpretation, NEOPLASMA, vol. 46, br. 6, str. 394-399 (Article)